NCT04698759 is a clinical trial of No Intervention in Immune Deficiency, sponsored by Bina Nusantara University.

Who is sponsoring NCT04698759?

NCT04698759 is sponsored by Bina Nusantara University.

What drugs are being tested in NCT04698759?

Interventions in NCT04698759: No Intervention.

What condition does NCT04698759 study?

NCT04698759 studies Immune Deficiency, Stunting, Fatty Acid.

Is NCT04698759 still recruiting?

NCT04698759 is currently completed. Last updated 15 January 2021.

Last reviewed 2021-01-15 · How we verify

NCT04698759

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immune and Scfa Profile of Stunting Children

Completed Last updated 15 January 2021

What this trial tests

trial testing No Intervention in Immune Deficiency in 131 participants. Completed in 11 November 2020.

Timeline

9 January 2020

Primary endpoint
11 October 2020

11 November 2020

Quick facts

Lead sponsor	Bina Nusantara University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	131
Start date	9 January 2020
Primary completion	11 October 2020
Estimated completion	11 November 2020
Sites	1 location across Indonesia

Drugs / interventions tested

No Intervention

Conditions studied

Immune Deficiency — all drugs for Immune Deficiency →
Stunting — all drugs for Stunting →
Fatty Acid — all drugs for Fatty Acid →

Sponsor

Bina Nusantara University

Who can join

Adults 3 to 5, any sex, with Immune Deficiency or Stunting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Type and Research Design A cross-sectional study design with a quantitative approach will be conducted. Cross-sectional research design is one-time research to find a relationship between the independent variable (risk factor) and the dependent variable (effect). 2. Time and Location of Research The research will be conducted for approximately six months in 2020 at Banten Regency (namely Tegal Ongok and Pasirkarang) and Sumedang Regency. 3. Population and Research Sample The population is children between three and five years old in the village of stunting locus. The sampling method to be used in this research was quota sampling, namely 50 stunting and 50 healthy children from each Regency.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Differences in immune status and fecal SCFA between Indonesian stunted children and children with normal nutritional status.
Surono IS, Jalal F, Bahri S, Romulo A, et al · · 2021 · cited 7× · PMID 34324500 · DOI 10.1371/journal.pone.0254300

Verify or expand the search:

Other trials of No Intervention

Trials testing the same drug.

NCT07353099 — A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma · not yet recruiting
NCT07429942 — A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Recei · not yet recruiting
NCT07521917 — Child Abuse and Neglect Awareness Training in Nursing Students · NA · not yet recruiting
NCT07319832 — A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome · recruiting
NCT07425574 — A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · recruiting

Other recruiting trials for Immune Deficiency

Currently open trials in the same condition.

NCT06689800 — Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy · NA · recruiting
NCT06278337 — X-linked Moesin Associated Immunodeficiency · recruiting
NCT04448951 — Immune Homeostasis in Sepsis and Septic Shock · recruiting

Other Bina Nusantara University trials

Trials by the same sponsor.

NCT05119218 — Gut Microbiota Stunted Children NTT · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04698759 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bina Nusantara University
Last refreshed: 15 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04698759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing